Literature DB >> 21292008

No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England.

Richard Pebody1, Nick Andrews, Pauline Waight, Rashmi Malkani, Christine McCartney, Joanna Ellis, Elizabeth Miller.   

Abstract

This study reports effectiveness of trivalent influenza vaccine (TIV) against confirmed pandemic influenza infection in England using a retrospective test-negative case-control study. Cases and controls were frequency matched by age, swabbing-week and region. On univariable and multivariable analysis adjusted for underlying clinical risk factors, cases were no more or less likely than controls to be vaccinated with 2008-09 or 2007-08 season TIV. Adjusted vaccine effectiveness for the former was -6% (-43% to 22%). Vaccine effectiveness did not differ significantly by age-group or hospitalisation status. There was no evidence prior vaccination with TIV significantly altered subsequent risk of pandemic influenza H1N1 2009 infection.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21292008     DOI： 10.1016/j.vaccine.2011.01.046

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  12 in total

Review 1.  Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review.

Authors:  Sheena G Sullivan; Shuo Feng; Benjamin J Cowling
Journal:  Expert Rev Vaccines       Date:  2014-10-28       Impact factor: 5.217

2.  The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology.

Authors:  Huiying Chua; Shuo Feng; Joseph A Lewnard; Sheena G Sullivan; Christopher C Blyth; Marc Lipsitch; Benjamin J Cowling
Journal:  Epidemiology       Date:  2020-01       Impact factor: 4.822

Review 3.  Partial protection against 2009 pandemic influenza A (H1N1) of seasonal influenza vaccination and related regional factors: Updated systematic review and meta-analyses.

Authors:  Zhi-yuan Li; Jin-yan Chen; Yan-ling Zhang; Wei-ming Fu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Pandemic influenza A(H1N1)pdm09: risk of infection in primary healthcare workers.

Authors:  Ben Hudson; Les Toop; Dee Mangin; Cheryl Brunton; Lance Jennings; Lynn Fletcher
Journal:  Br J Gen Pract       Date:  2013-06       Impact factor: 5.386

5.  Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls.

Authors:  Wiebke Hellenbrand; Pernille Jorgensen; Brunhilde Schweiger; Gerhard Falkenhorst; Matthias Nachtnebel; Benedikt Greutélaers; Christian Traeder; Ole Wichmann
Journal:  BMC Infect Dis       Date:  2012-05-31       Impact factor: 3.090

6.  Serologic survey of the pandemic H1N1 2009 virus in Guangdong Province, China: a cross sectional study.

Authors:  Xin Zhang; Jianfeng He; Linghui Li; Xiaolan Zhu; Changwen Ke; Hanzhong Ni; Nianmei Hou; Haojie Zhong; Jie Wu
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

7.  No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009.

Authors:  Salaheddin M Mahmud; Paul Van Caeseele; Gregory Hammond; Carol Kurbis; Tim Hilderman; Lawrence Elliott
Journal:  Emerg Infect Dis       Date:  2012-05       Impact factor: 6.883

8.  Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico.

Authors:  Gerardo Chowell; Santiago Echevarría-Zuno; Cécile Viboud; Lone Simonsen; Mark A Miller; Irma Fernández-Gárate; Cesar González-Bonilla; Víctor H Borja-Aburto
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

9.  Factors associated with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus in the French general population.

Authors:  Nathanael Lapidus; Xavier de Lamballerie; Nicolas Salez; Michel Setbon; Rosemary M Delabre; Pascal Ferrari; Nanikaly Moyen; Marie-Lise Gougeon; Frédéric Vely; Marianne Leruez-Ville; Laurent Andreoletti; Simon Cauchemez; Pierre-Yves Boëlle; Eric Vivier; Laurent Abel; Michaël Schwarzinger; Michèle Legeas; Pierre Le Cann; Antoine Flahault; Fabrice Carrat
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

10.  The effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong, 2009-2013.

Authors:  Benjamin J Cowling; Kwok-Hung Chan; Shuo Feng; Eunice L Y Chan; Janice Y C Lo; J S Malik Peiris; Susan S Chiu
Journal:  Vaccine       Date:  2014-08-01       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.